drugset / Trial / NCT02957435
Pharmacokinetics Study of Eplerenone Coated Tablets
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the pharmacokinetics profile of the formulation of eplerenone coated tablets in the concentration of 25mg, 50mg and 100mg (2 coated tablets of 50mg) in male and female healthy subjects under fasting condition.
Timeline
- Start
- 2017-07
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eplerenone | Unknown | 25 mg | Oral |
| Subject | Eplerenone | Unknown | 50 mg | Oral |
| Subject | Eplerenone | Unknown | 100 mg | Oral |
Indications
No indication recorded.